Sign Up Today and Learn More About Swing Therapeutics Stock
Invest in or calculate the value of your shares in Swing Therapeutics or other pre-IPO companies through EquityZen's platform.
Swing Therapeutics Stock (SWIT)
Swing Therapeutics provides digital therapeutics for people with chronic conditions.
About Swing Therapeutics Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Financial Services
Swing Therapeutics Press Mentions
Stay in the know about the latest news on Swing Therapeutics
Highmark Covers New FDA-Cleared Treatment for Fibromyalgia Symptoms from Swing Therapeutics
biospace • Feb 05, 2025
Chronic pain management through digital therapy system
patents • Dec 06, 2024
Why clinical trials for digital therapeutics are getting more rigorous
statnews • Aug 05, 2024
Swing Therapeutics Announces The Lancet Publication of Data from Phase 3 Trial of Stanza™ - a Digital Behavioral Therapy for Fibromyalgia Symptoms
biospace • Aug 05, 2024
Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia
dlvr • May 22, 2023
Swing Therapeutics Management
Leadership team at Swing Therapeutics
CEO
Mike Rosenbluth
Head of Software Engineering
Eric Hoppe
Join now and verify your accreditation status to gain access to:
- Swing Therapeutics Current Valuation
- Swing Therapeutics Stock Price
- Swing Therapeutics Management
- Available deals in Swing Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Swing Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Swing Therapeutics Revenue and Financials
- Swing Therapeutics Highlights
- Swing Therapeutics Business Model
- Swing Therapeutics Risk Factors
- Swing Therapeutics Research Report from SACRA Research
Trading Swing Therapeutics Stock
How to invest in Swing Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Swing Therapeutics through EquityZen funds. These investments are made available by existing Swing Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Swing Therapeutics stock?
Shareholders can sell their Swing Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
